{
  "doc_id": "Determina_33-2024_Lumykras",
  "created_date": "2024",
  "country": "IT",
  "source_type": "hta_submission",
  "chunks": [
    {
      "heading": "",
      "text": "dell dell (Det (modi modi l'8 8 (10) No No 33/2024). (24A02603) of of 25-5-2024)",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "THE PRESIDENT",
      "text": "the the drug; 8 8 (10), Health Health Service; combating combating doping; 48 48 (3) monitoring monitoring registers; Regulation Regulation (EC) No 1394/Directive Directive 2001/83/Regulation Regulation (EEC) regulation regulation (EC). class class a) Service Service (SSN) 48 48 (5) (c) 326 326 (Prontuario Prontuario 2006) , Republic Republic - General Series - letter letter c), 326 326 (medicine medicine 2006) Health Health Service; official official documents; Determines: LUMYKRAS LUMYKRAS (sotorasib) as as follows: of of negotiation: Packaging: (PVC/PE/PE /PVDC/alu) 240 tablets - No No 049858018/E (base 10) - class of refundableness': H - ex-factory price (excluding VAT) 00 00 - public price (VAT included) euro 12160,24; of of AIFA: Protocol. Protocol.",
      "start_page": 1,
      "end_page": 5
    }
  ]
}